| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324993A2 Substituted 1,4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1324809A1 Process for selectively extracting bioactive components |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
| 07/09/2003 | EP1164140B1 Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs |
| 07/09/2003 | EP1164139B1 Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP0988056B1 Tissue factor methods and compositions for coagulation and tumor treatment |
| 07/09/2003 | EP0966465B1 Inhibitors of impdh enzyme |
| 07/09/2003 | EP0914340B1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE |
| 07/09/2003 | EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein |
| 07/09/2003 | EP0717631B1 Immunomodulating compositions from bile |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | EP0190315B2 Dehydrated liposomes |
| 07/09/2003 | CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
| 07/09/2003 | CN1429224A Novel benzothiophene derivatives |
| 07/09/2003 | CN1429223A Novel benzofuran derivatives |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429221A 2-phenylpyran-4-one derivatives |
| 07/09/2003 | CN1429213A Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 07/09/2003 | CN1429203A Sponge antitumor compounds |
| 07/09/2003 | CN1429202A Compounds for modulating cell proliferation |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429121A Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1429116A Pharmaceutical composition |
| 07/09/2003 | CN1429114A 联合化学疗法 Combined chemotherapy |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1429111A Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429106A Methods for inhibiting angiogenesis and tumor growth |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1429097A Use of ellagic acid as anti-pollution cosmetic agent |
| 07/09/2003 | CN1429073A A gene therapy system and method using alpha-MSH and its derivatives |
| 07/09/2003 | CN1428350A Antineoplastic compound Intercedenside C in bicolor table ginseng |
| 07/09/2003 | CN1428347A Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/09/2003 | CN1428168A Formula of liquid medicine for curing various intermediate and late cancers and AIDS |
| 07/09/2003 | CN1428152A Chinese medicine for curing liver cancer and pancreatic cancer |
| 07/09/2003 | CN1428151A Chinese medicine composition for curing cough with dyspnea due to pulmonary disease-compound Runfei kechuanning medicine |
| 07/09/2003 | CN1113888C Tetraphosphonate bicyclic trisanhydrides |
| 07/09/2003 | CN1113882C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 07/09/2003 | CN1113871C 9-aminoacridine derivatives and process for preparation thereof |
| 07/09/2003 | CN1113869C Two aporphine-benzyl isoquinoline compounds with antitumour activity |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/09/2003 | CN1113652C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignant tumour |
| 07/09/2003 | CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590086 Mutants of the Rb and p53 genes and uses thereof |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6589988 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 07/08/2003 | US6589987 Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and |
| 07/08/2003 | US6589981 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 07/08/2003 | US6589979 Derivatives of seco-baccatine III, with bioavailability through the oral route, reduced toxicity and high antiangiogenetic activity; use as antiarthritic agent as well |
| 07/08/2003 | US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects |
| 07/08/2003 | US6589971 A method of treatment of a neoplastic disease in a patient in need of said treatment by administering a therapeutically effective amount of a compound of the formula: bind to specific sequences in the minor groove of duplex DNA, and to |
| 07/08/2003 | US6589966 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: |
| 07/08/2003 | US6589961 9-alkylamino-1-nitroacridine derivatives |
| 07/08/2003 | US6589941 Preventing or reducing formation of resistance in cytostatic treatment comprising combining BVDU, a salt thereof or BVDU in protected form or in prodrug form with at least one cytostatic agent in order to prevent or reduce the formation |
| 07/08/2003 | US6589939 Camptothecin derivatives having antitumor activity |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589567 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition |
| 07/08/2003 | US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate |
| 07/08/2003 | US6589549 Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| 07/08/2003 | US6589546 Polymeric coatings for controlled delivery of active agents |
| 07/08/2003 | US6589531 Recombinant yellow fever virus and method of use thereof |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2197139C A drug for the treatment of cancer |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof |
| 07/03/2003 | WO2003054193A2 Raf/ras binding compounds |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003054008A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 07/03/2003 | WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 07/03/2003 | WO2003053999A2 Selective arylguanidine peptides as urokinase inhibitors |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |